BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12928390)

  • 1. TCR binding kinetics measured with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for TCR.
    Holmberg K; Mariathasan S; Ohteki T; Ohashi PS; Gascoigne NR
    J Immunol; 2003 Sep; 171(5):2427-34. PubMed ID: 12928390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidic termini play a significant role in TCR recognition.
    Wang B; Sharma A; Maile R; Saad M; Collins EJ; Frelinger JA
    J Immunol; 2002 Sep; 169(6):3137-45. PubMed ID: 12218131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent T cell agonism mediated by a very rapid TCR/pMHC interaction.
    Boulter JM; Schmitz N; Sewell AK; Godkin AJ; Bachmann MF; Gallimore AM
    Eur J Immunol; 2007 Mar; 37(3):798-806. PubMed ID: 17295390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-specific selection of MHC class II-restricted thymocytes in fetal thymic organ culture.
    Kersh GJ; Engle DL; Williams CB; Allen PM
    J Immunol; 2000 Jun; 164(11):5675-82. PubMed ID: 10820243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness.
    Huang J; Zarnitsyna VI; Liu B; Edwards LJ; Jiang N; Evavold BD; Zhu C
    Nature; 2010 Apr; 464(7290):932-6. PubMed ID: 20357766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.
    Denkberg G; Cohen CJ; Reiter Y
    J Immunol; 2001 Jul; 167(1):270-6. PubMed ID: 11418659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of T cell function by TCR/pMHC binding kinetics.
    Carreño LJ; González PA; Kalergis AM
    Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A physiological ligand of positive selection is recognized as a weak agonist.
    Berg RE; Irion S; Kattman S; Princiotta MF; Staerz UD
    J Immunol; 2000 Oct; 165(8):4209-16. PubMed ID: 11035053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.
    Kerry SE; Buslepp J; Cramer LA; Maile R; Hensley LL; Nielsen AI; Kavathas P; Vilen BJ; Collins EJ; Frelinger JA
    J Immunol; 2003 Nov; 171(9):4493-503. PubMed ID: 14568922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
    Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
    J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homology between an alloantigen and a self MHC allele calibrates the avidity of the alloreactive T cell repertoire independent of TCR affinity.
    Hornell TM; Myers N; Hansen TH; Connolly JM
    J Immunol; 2003 May; 170(9):4506-14. PubMed ID: 12707327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.
    González PA; Carreño LJ; Coombs D; Mora JE; Palmieri E; Goldstein B; Nathenson SG; Kalergis AM
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4824-9. PubMed ID: 15772168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.
    O'Herrin SM; Lebowitz MS; Bieler JG; al-Ramadi BK; Utz U; Bothwell AL; Schneck JP
    J Exp Med; 1997 Oct; 186(8):1333-45. PubMed ID: 9334373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
    Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
    Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.
    Buslepp J; Kerry SE; Loftus D; Frelinger JA; Appella E; Collins EJ
    J Immunol; 2003 Jan; 170(1):373-83. PubMed ID: 12496422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits to the differential avidity model of T cell selection in the thymus.
    Girao C; Hu Q; Sun J; Ashton-Rickardt PG
    J Immunol; 1997 Nov; 159(9):4205-11. PubMed ID: 9379014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct T cell interactions with HLA class II tetramers characterize a spectrum of TCR affinities in the human antigen-specific T cell response.
    Reichstetter S; Ettinger RA; Liu AW; Gebe JA; Nepom GT; Kwok WW
    J Immunol; 2000 Dec; 165(12):6994-8. PubMed ID: 11120826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.
    Stefanski HE; Mayerova D; Jameson SC; Hogquist KA
    J Immunol; 2001 Jun; 166(11):6602-7. PubMed ID: 11359813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.
    Maile R; Siler CA; Kerry SE; Midkiff KE; Collins EJ; Frelinger JA
    J Immunol; 2005 Jan; 174(2):619-27. PubMed ID: 15634879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies directed against the MHC-I molecule H-2Dd complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity.
    Polakova K; Plaksin D; Chung DH; Belyakov IM; Berzofsky JA; Margulies DH
    J Immunol; 2000 Nov; 165(10):5703-12. PubMed ID: 11067928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.